Liquid biopsy is an easy and non-invasive way to detect and treat lung cancer But is it as accurate as traditional biopsies ...

Oxford University researchers have unveiled a new blood test, powered by machine learning, that shows promise in detecting ...

Oxford University researchers have unveiled a new blood test, powered by machine learning, which shows real promise in ...

Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests for ...

Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic ...

Enea TECH and Biomedical Foundation announces a €15 million investment in Tethis S.p.A., a Milan-based company at the ...

Breast cancer liquid biopsy industry is projected to witness a CAGR of 22.6% during the period 2024-2032. This growth can be ...

The platform analyses gene expression and cell states specific to individual cells, offering insights for disease diagnosis.

Oxford Cancer Analytics Raises USD$11M in Series A Funding to Transform Early Lung Cancer Detection and Enable Curative ...

In a report released yesterday, Michael Ryskin from Bank of America Securities maintained a Buy rating on Guardant Health (GH – Research ...